Fig. 5. LINC01232 overexpression facilitated cell proliferation and angiogenesis by decreasing miR-181a-5p level.
(A-B). The transfection efficiency of miR-181a-5p mimic and miR-181a-5p inhibitor was detected by qRT-PCR. U6 acted as an internal reference. (C-D). CCK-8 assay was carried out to examine the proliferation of SW-620 and LOVO cells transfected or untransfected with siLINC01232, LINC01232 overexpression plasmid, miR-181a-5p mimic and miR-181a-5p inhibitor. (E-H). Tubule formation assay was applied to determine the angiogenesis of SW-620 and LOVO cells transfected or untransfected with siLINC01232, LINC01232 overexpression plasmid, miR-181a-5p mimic and miR-181a-5p inhibitor. *vs. IC+siNC, ^vs. I+siNC, #vs. IC+siLINC01232, &vs. MC+NC, Δ vs. M+NC, †vs. MC+LINC01232; *or^or#or&or†p < 0.05, **or ΔΔ or†† or&&p < 0.01, ***or^^^ or ### or&&& or ΔΔΔ or †††p < 0.001. qRT-PCR, quantitative reverse transcription polymerase chain reaction; CCK-8, cell counting kit-8; I, miR-181a-5p inhibitor; IC, inhibitor control; M, miR-181a-5p mimic; MC, mimic control; siNC, siRNA negative control.